EP Patent

EP0089815A1 — Liquid perfluorocarbons, for use in ocular therapy, and preparations containing them

Assigned to Individual · Expires 1983-09-28 · 43y expired

What this patent protects

Perfluorocyclocarbons used in the treatment of the eye. In particular perfiuoro-1-methyldecalin is preferred.

USPTO Abstract

Perfluorocyclocarbons used in the treatment of the eye. In particular perfiuoro-1-methyldecalin is preferred.

Drugs covered by this patent

Patent Metadata

Patent number
EP0089815A1
Jurisdiction
EP
Classification
—
Expires
1983-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.